This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Logo

3D Printed vs. Milled Occlusal Splints in Dentistry

Sponsored by Radboud University Medical Center

About this trial

Last updated 6 months ago

Study ID

2024-17704

Status

Not yet recruiting

Type

Observational

Placebo

No

Accepting

18 to 45 Years
All Sexes

Trial Timing

Started 5 months ago

What is this trial about?

This crossover study aims to evaluate the wear comfort, retention, and stability of 3D-printed and milled occlusal splints in healthy subjects. The main question it aims to answer is: Research questions - How do healthy subjects experience the wear comfort, fitting, retention and stability of a printed and milled occlusal splint? and how do clinicians experience the fitting, retention and stability of the splints? By systematically assessing self-reported outcomes, this research seeks to contribute valuable insights into the practical applications of both technologies. The findings may not only enhance our understanding of patient preferences but also guide future developments in the design and manufacturing of occlusal splints, ultimately improving patient care in dental practice.

What are the participation requirements?

Inclusion Criteria

* Subjects being healthy (ASA <IV)

* Subjects with healthy, complete dentitions (except for extractions of wisdom teeth, or tooth extractions for the purpose of orthodontic treatment in the past)

* Subjects willing and able to participate in the study

* Subjects willing to provide written informed consent for their participation in the study

Exclusion Criteria

* Subjects with dental issues other than the inclusion criteria

* Subjects with a history of autoimmune disorder

* Subjects with known allergies to acrylic materials

* Subjects with severe allergies manifested by a history of anaphylaxis or those with severe, chronic allergies (e.g., asthma) and subjects with an active infection of any kind at the time of enrollment

* Subjects who are pregnant or lactating

* Subjects enrolled in another investigational clinical trial